Prevention, recognition and management of neonatal HSV infections

Expert Review of Anti-Infective Therapy

Volumn 10, Issue 6, 2012, Pages 675-685

  Robinson, Joan L ^a   Vaudry, Wendy L ^a   Forgie, Sarah E ^a   Lee, Bonita E ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

congenital infection; herpes simplex virus; intrauterine infection; neonatal infection; perinatal infection

Indexed keywords

ACICLOVIR; PLACEBO; VALACICLOVIR;

AWARENESS; CEREBROSPINAL FLUID ANALYSIS; CESAREAN SECTION; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SURVEILLANCE; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FALSE POSITIVE RESULT; GENITAL HERPES; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HUMAN; INFECTION PREVENTION; INFECTION RISK; MATERNAL CARE; MEDICAL DECISION MAKING; MEDICAL INFORMATION; MOLECULAR RECOGNITION; NEPHROTOXICITY; NEUTROPENIA; NEWBORN; NEWBORN CARE; NEWBORN INFECTION; NEWBORN MORTALITY; NONHUMAN; OUTCOME ASSESSMENT; POINT OF CARE TESTING; POLYMERASE CHAIN REACTION; PREDICTION; PROGNOSIS; RECOMMENDED DRUG DOSE; RECURRENT INFECTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEIZURE; SEROPREVALENCE; SYNDROME DELINEATION; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT PLANNING; VAGINAL DELIVERY; VIRUS TRANSMISSION;

ACYCLOVIR; ANTIVIRAL AGENTS; FEMALE; HERPES GENITALIS; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 84863210197     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.12.55     Document Type: Review

References (59)

1. Marquez L, Levy ML, Munoz FM, Palazzi DL. A report of three cases and review of intrauterine herpes simplex virus infecion. Pediatr. Infect. Dis. J. 30(2), 153-156 (2011).
2. Kropp RY, Wong T, Cormier L et al. Neonatal herpes simplex virus infections in Canada: results of a 3-year national prospective study. Pediatrics 117(6), 1955-1962 (2006). (Pubitemid 46071239)
3. Tronstein E, Johnston C, Huang M et al. Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection. JAMA 305(14), 1441-1449 (2011).
4. Rathore S, Jamwal A, Gupta V. Herpes simplex virus type 2: seroprevalence in antenatal women. Ind. J. Sex Trasm. Dis. 31(1), 11-15 (2010).
5. Schneider JA, Lakshmi V, Dandona R, Kumar GA, Sudha T, Dandona L. Population-based serorpevalence of HSV-2 and sypilis in Andhra Pradesh state of India. BMC Infect. Dis. 10, 59 (2010).
6. Biswas D, Borkakoty B, Mahanta J et al. Seroprevalence and risk factors of herpes simplex virus type-2 infection among pregnant women in Northeast India. BMC Infect. Dis. 11(1), 325 (2011).
7. Li JM, Chan YR, Li XT, Xu WC. Screening of herpes simplex 2 virus infection among pregnant women in southern China. J. Dermatol. 38(2), 120-124 (2011).
8. Lin H, He N, Su M, Feng J, Chen L, Gao M. Herpes simplex virus infections among rural residents in eastern China. BMC Infect. Dis. 11, 69 (2011).
9. Nyiro JU, Sanders EJ, Ngetsa C et al. Seroprevalence, predictors and estimated incidence of maternal and neonatal Herpes Simplex Virus type 2 infection in semi-urban women in Kilifi, Kenya. BMC Infect. Dis. 11, 155 (2011).
10. Mmbaga EJ, Leyna GH, Stray-Pedersen B, Klepp KI. Herpes simplex virus type-2 and human immunodeficiency virus infections in a rural population in Kilimanjaro, Tanzania. East Afr. J. Public Health 8(1), 28-32 (2011).
11. Vilibic-Cavlek T, Ljubin-Sternak S, Ban M, Kolaric B, Sviben M, Mlinaric- Galinovic G. Seroprevalence of TORCH infections in women of childbearing age in Croatia. Matern. Fetal Neonatal. Med. 24(2), 280-283 (2011).
12. Vilibic-Cavlek T, Kolaric B, Ljubin-Sternak S, Mlinaric-Galinovic G. Herpes simplex virus infection in the Croatian population. Scand. J. Infect. Dis. 43(11-12), 918-922 (2011).
13. Arama V, Cercel AS, Vladareanu R et al. Type-specific herpes simplex virus-1 and herpes simplex virus-2 seroprevalence in Romania: comparison of prevalence and risk factors in women and men. Intern. J. Infect. Dis. 14(Suppl. 3), E25-E31 (2010).
14. Kucera P, Gerber S, Marques-Vidal P, Meylan PR. Seroepidemiology of herpes simplex virus type 1 and 2 in pregnant women in Switzerland: an obstetric clinic based study. Eur. J. Obstet. Gynecol. Reprod. Biol. 160(1), 13-17 (2012).
15. Sauerbrei A, Schmitt S, Scheper T et al. Seroprevalence of herpes simplex virus type 1 and type 2 in Thuringia, Germany, 1999 to 2006. Eur. Surveill. 16(44), pii, 20005 (2011).
16. Sierra CA, Bedoya AM, Paris S et al. Prevalence of specific herpes simplex virus-2 antibodies and associated factors in women of a rural town of Colombia. Trans. R. Soc. Trop. Med. Hyg. 105(4), 232-238 (2011).
17. Clemens SAC, Farhat CK. Seroprevalence of herpes simplex 1-2 antibodies in Brazil. Rev. Saude Public 44(4), 1-8 (2010).
18. Pérez CM, Marrero E, Meléndez M et al. Seroepidemiology of viral hepatitis, HIV and herpes simplex type 2 in the household population aged 21-64 years in Puerto Rico. BMC Infect. Dis. 10, 76 (2010).
19. Centers for disease control. Seroprevalence of herpes simplex virus type 2 among persons aged 14-49 years - United States, 2005-2008. MMWR 59 15 456-459 (2010).
20. Molina M, Romaguera RA, Valentine J, Tao G. Seroprevalence of herpes simplex virus 2 among Hispanics in the USA: National Health and Nutrition Examination Survey, 2007-2008. Int. J. STD AIDS 22(7), 387-390 (2011).
21. Gilbert M, Li X, Petric M et al. Using centralized laboratory data to monitor trends in herpes simplex virus type 1 and 2 infection in British Columbia and the changing etiology of genital herpes. Can. J. Public Health 102(3), 225-229 (2011).
22. Lafferty WE, Downey L, Celum C, Wald A. Herpes simplex virus type 1 as a cause of genital herpes: impact on surveillance and prevention. J. Infect. Dis. 181(4), 1454-1457 (2000). (Pubitemid 30252554)
23. Gardella C, Brown Z. Prevention of neonatal herpes. BJOG 118(2), 187-192 (2011).
24. Handel S, Klinger EJ, Washburn K, Blank S, Schillinger JA. Population-based surveillance for neonatal herpes in New York City, April 2006-September 2010. Sex. Transmit. Dis. 38(8), 705-711 (2011).
25. Ratnam S, Severini A, Zahariadis G, Petric M, Romanowski B. The diagnosis of genital herpes - beyond culture: an evidence-based guide for the utilization of polymerase chain reaction and herpes simplex virus type-specific serology. Can. J. Infect. Dis. Med. Microbiol. 18(4), 233-240 (2007). (Pubitemid 47529018)
26. Gesundheit B, Grisaru-Soen G, Greenberg D et al. Neonatal genital herpes simplex virus type 1 infection after Jewish ritual circumcision: modern medicine and religious tradition. Pediatrics 114(2), E259-E263 (2004).
27. Langenberg A, Benedetti J, Jenkins J, Ashley R, Winter C, Corey L. Deveopment of clinically recognizable genital lesions among women previously identified as having "asymptomatic" herpes simplex virus type 2 infection. Ann. Intern. Med. 119(11), 882-887 (1989). (Pubitemid 19153773)
28. Brown ZA, Wald A, Morrow RA, Selke S, Zeh J, Corey L. Effect of serologic status and Cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 289(2), 203-209 (2003). (Pubitemid 36068708)
29. Corey L, Wald A. Maternal and neonatal HSV infections. N. Engl. J. Med. 361(14), 1376-1385 (2009).
30. Diamond C, Selke S, Ashley R, Benedetti J, Corey L. Clinical course of patients with serologic evidence of recurrent genital herpes presenting with signs and symptoms of first episode disease. Sex. Transm. Dis. 26(4), 221-225 (1999). (Pubitemid 29174426)
31. Wald A, Ashley-Morrow R. Serological testing for herpes simplex virus (HSV)-1 and HSV-2 infection. Clin. Infect. Dis. 35(Suppl. 2), S173-S182 (2002). (Pubitemid 35178328)
32. Ashley-Morrow R, Krantz E, Wald A. Time course of seroconversion by Herpe select ELISA after acquisition of genital herpes simplex virus type 1 (HSV-1) or HSV-2. Sex. Transm. Dis. 30(4), 310-314 (2003). (Pubitemid 36397831)
33. Money D, Steben M. Infectious Diseases Committee, Society of Obstetricians and Gynaecologists of Canada. JOGC 208(6), 514-518 (2008).
34. American Academy of Pediatrics. Herpes simplex virus. In: Red Book: 2009 Report of the Committee on Infections Diseases (28th Edition). Pickering LK, Backer CJ, Kimberlin DW, Long SS (Eds). American Academy of Pediatrics, IL, USA, 370 (2009).
35. Swiss Herpes Management Forum. Swiss recommendations for the management of genital herpes and herpes simplex virus infection of the neonate. Swiss Med. Wkly 134(15-16), 205-214 (2004).
36. Brown ZA, Selke S, Zeh J et al. The acquisition of herpes simplex virus during pregnancy. N. Engl. J. Med. 337(8), 509-515 (1997). (Pubitemid 27352016)
37. Randolph AG, Washington AE, Prober CG. Cesarian delivery for women presenting with genital herpes lesions: efficacy, risks, and costs. JAMA 270(1), 77-82 (1993). (Pubitemid 23202656)
38. Peng J, Krause PJ, Kresch M. Neonatal herpes simplex virus infection after Cesarean section with intact amniotic membranes. J. Perinatol. 16(5), 397-399 (1996). (Pubitemid 126432847)
39. Hollier LM, Wendel GD. Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) recurrences and neonatal infection. Cochrane Database Syst. Rev. (1), CD004946 (2008).
40. Pinninti SG, Angara R, Feja KN et al. Neonatal herpes disease despite maternal antenatal antiviral suppressive therapy: a multicenter case series. J. Pediatr. doi:10.1016/j.jpeds.2011.12.053 (2012) (Epub ahead of print).
41. Mertz GJ, Benedetti J, Ashley R, Selke SA, Corey L. Risk factors for the sexual transmission of genital herpes. Ann. Intern. Med. 116(3), 197-202 (1992).
42. Corey L, Wald A, Patel R et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N. Engl. J. Med. 350(1), 11-20 (2004). (Pubitemid 38032179)
43. Kulhanjian JA, Soroush V, Au DS et al. Identification of women at unsuspected risk of primary infection with herpes simplex virus type 2 during pregnancy. N. Engl. J. Med. 326(14), 916-920 (1992).
44. Tuite AR, McCabe CJ, Ku J, Fisman DN. Projected cost-savings with herpes simplex virus screening in pregnancy: towards a new screening paradigm. Sex Transm. Infect. 87(2), 141-148 (2011).
45. Carver JA, Arnoldi SH, Abel DM, Olson LC, Hall RT. Asymptomatic neonatal contamination with herpes simplex virus. J. Perinatol. 8(1), 14-16 (1988).
46. Arvin AM, Hesnlsigh P, Prober CG et al. Failure of antepartum maternal cultures to predict the infants risk of exposure to herpes simplex virus at delivery. N. Engl. J. Med. 315(13), 796-800 (1986). (Pubitemid 16014342)
47. Ratnam S, Severini A, Zahariadis G, Petric M, Romanowski B. The diagnosis of genital herpes - beyond culture: an evidence-based guide for the utilization of polymerase chain reaction and herpes simplex type-specific serology. Can. J. Infect. Dis. Med. Microbiol. 18(4), 233-240 (2007). (Pubitemid 47529018)
48. Whitley RJ, Nahmias AJ, Visintine AM, Fleming CL, Alford DA. The natural history of herpes simplex virus infection of mother and newborn. Pediatrics 66(4), 489-494 (1980). (Pubitemid 10018428)
49. Whitley RJ, Nahmias AJ, Soong SJ, Galasso GG, Fleming CL, Alford CA. Vidarabine therapy of neonatal herpes simplex virus infection. Pediatrics 66(4), 495-501 (1980). (Pubitemid 10018429)
50. Long SS, Pool TE, Vodzak J, Daskalaki I, Gould JM. Herpes simplex virus infection in young infants during 2 decades of empiric acyclovir therapy. Pediatr. Infect. Dis. J. 30(7), 556-561 (2011).
51. Kimberlin DW, Lin C, Jacobs RF. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics 108(2), 223-229 (2001).
52. Koskiniemi M, Happonen J, Jarvenpaa A et al. Neonatal herpes simplex virus infection: a report of 43 patients. Pediatr. Infect. Dis. J. 8(1), 30-35 (1989). (Pubitemid 19034414)
53. Chien LT, Whitley RJ, Nahmias AJ et al. Antiviral chemotherapy and neonatal herpes simplex virus infection: a pilot study - experience with adenine arabinoside (ARA-A). Pediatrics 55(5), 678-685 (1975).
54. Skoldenberg B, Aurelius E, Hjallmarsson A et al. Incidence and pathogenesis of clinical relapse after herpes simplex encephalitis in adults. J. Neurol. 253(2), 163-170 (2006). (Pubitemid 43255885)
55. Thompsn C, Whitley R. Neonatal herpes simplex virus infections: where are we now? Adv. Exp. Med. Biol. 697, 221-230 (2011).
56. Lewensohn-Fuchs I, Osterwall P, Forsgren M, Malm G. Detection of herpes simplex virus DNA in dried blood spots making a retrospective diagnosis possible. J. Clin. Virol. 26(1), 39-48 (2003).
57. Westoff GL, Little SE, Caughery AB. Herpes simplex virus and pregnancy: a review of the management of antenatal and peripartum herpes infections. Obstet. Gyne. Survey 66(10), 629-638 (2011).
58. Kimberlin DW, Whitley RJ, Wan W et al. National Institute of allergy and infectious diseases collaborative antiviral study group. Oral acyclovir suppression and neurodevelopment after neonatal herpes. N. Engl. J. Med. 365(14), 1284-1292 (2011).
59. Whitley R, Arvin A, Prober C et al. National Institute of allergy and infectious diseases collaborative antiviral study group. Predictors of morbidity and mortality in neonates with herpes simplex virus infections. N. Engl. J. Med. 324(7), 450-454 (1991). Management of genital herpes in pregnancy. www.rcog.org.uk/files/rcog-corp/uploaded-files/GT30GenitalHerpes2007.pdf